Service d'Anesthésie Réanimation Chirurgicale, Hôpital Raymond Poincaré, Assistance Publique Hôpitaux de Paris, 104 boulevard Raymond Poincaré F-92380 Garches, France
INSERM, U-987, Hôpital Ambroise Paré, Centre d'Evaluation et de Traitement de la Douleur, F-92100 France, Université Versailles Saint-Quentin, F-78035, France.
Br J Anaesth. 2017 Jan;118(1):22-31. doi: 10.1093/bja/aew391.
Morphine, and analgesics other than morphine (AOM), are commonly used to treat postoperative pain after major surgery. However, which AOM provides the best efficacy-safety profile remains unclear.
Randomized trials of any AOM alone or any combination of AOM compared with placebo or another AOM in adults undergoing major surgery and receiving morphine patient-controlled analgesia were included in a network meta-analysis. The outcomes were morphine consumption, pain, incidence of nausea, vomiting at 24 h and severe adverse effects.
135 trials (13,287 patients) assessing 14 AOM alone or in combination were included. For all outcomes, comparisons with placebo were over-represented. Few trials assessed combinations of two AOM and none the combination of three or more. Network meta-analysis found morphine consumption reduction was greatest with the combination of two AOM (acetaminophen + nefopam, acetaminophen + NSAID, and tramadol + metamizol): -23.9 (95% CI -40;-7.7), -22.8 (-31.5;-14) and -19.8 (35.4;-4.2) mg per 24 h, respectively. For AOM used alone, morphine consumption reduction was greatest with α-2 agonists, NSAIDs, and COX-2 inhibitors. When considering the risk of nausea, NSAIDs, corticosteroids and α-2 agonists used alone were the most efficacious (OR 0.7 [95% CI: 0.6-0.8], 0.36 [0.18-0.79], 0.41 [0.15-.64], respectively). The paucity of severe adverse effects data did not allow assessment of efficacy-safety balance.
A combination of aetaminophen with either an NSAID or nefopam was superior to most AOM used alone, in reducing morphine consumption. Efficacy was best with three AOM used alone (α-2 agonists, NSAIDs and COX-2 inhibitors) and least with tramadol and acetaminophen. There is insufficient trial data reporting adverse events.
PROSPERO: CRD42013003912.
吗啡和除吗啡以外的镇痛剂(AOM)常用于治疗大手术后的术后疼痛。然而,哪种 AOM 具有最佳的疗效-安全性仍不清楚。
我们对接受大手术并接受吗啡患者自控镇痛的成年人进行了任何 AOM 单独或任何 AOM 联合与安慰剂或另一种 AOM 进行的随机试验进行了网络荟萃分析。结局为吗啡用量、疼痛、恶心、呕吐发生率 24 小时和严重不良反应。
共纳入 135 项试验(13287 例患者),评估了 14 种 AOM 单独或联合应用。对于所有结局,与安慰剂相比,比较结果的代表性过高。很少有试验评估两种 AOM 的联合使用,也没有试验评估三种或更多种 AOM 的联合使用。网络荟萃分析发现,两种 AOM 联合使用(对乙酰氨基酚+奈福泮、对乙酰氨基酚+非甾体抗炎药和曲马多+美沙酮)可最大程度减少吗啡用量:-23.9(95%CI-40;-7.7)、-22.8(-31.5;-14)和-19.8(35.4;-4.2)mg/24h。对于单独使用的 AOM,α-2 激动剂、非甾体抗炎药和 COX-2 抑制剂可最大程度减少吗啡用量。考虑到恶心的风险,单独使用 NSAIDs、皮质类固醇和 α-2 激动剂的疗效最高(OR0.7[95%CI:0.6-0.8]、0.36[0.18-0.79]、0.41[0.15-0.64])。由于严重不良事件数据不足,无法评估疗效-安全性平衡。
对乙酰氨基酚与 NSAID 或奈福泮联合使用优于大多数单独使用的 AOM,可减少吗啡用量。三种 AOM 单独使用(α-2 激动剂、非甾体抗炎药和 COX-2 抑制剂)的疗效最佳,而曲马多和对乙酰氨基酚的疗效最差。报告不良事件的试验数据不足。
PROSPERO:CRD42013003912。